Two-gene signature improves the discriminatory power of IASLC/ATS/ERS classification to predict the survival of patients with early-stage lung adenocarcinoma.
about
P2860
Two-gene signature improves the discriminatory power of IASLC/ATS/ERS classification to predict the survival of patients with early-stage lung adenocarcinoma.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Two-gene signature improves th ...... rly-stage lung adenocarcinoma.
@en
Two-gene signature improves th ...... rly-stage lung adenocarcinoma.
@nl
type
label
Two-gene signature improves th ...... rly-stage lung adenocarcinoma.
@en
Two-gene signature improves th ...... rly-stage lung adenocarcinoma.
@nl
prefLabel
Two-gene signature improves th ...... rly-stage lung adenocarcinoma.
@en
Two-gene signature improves th ...... rly-stage lung adenocarcinoma.
@nl
P2093
P2860
P356
P1476
Two-gene signature improves th ...... rly-stage lung adenocarcinoma.
@en
P2093
Huikang Xie
Yifeng Sun
Zhigang Li
P2860
P304
P356
10.2147/OTT.S107272
P407
P577
2016-07-25T00:00:00Z